Literature DB >> 17574961

The origin of chromosome imbalances in neuroblastoma.

Raymond L Stallings1, Kihoon Yoon, Stephen Kwek, Daijin Ko.   

Abstract

Many recurrent large-scale chromosome abnormalities associated with poor clinical outcomes have been identified in neuroblastoma, a pediatric tumor that accounts for 15% of childhood cancer deaths. We have previously used high-resolution oligonucleotide array comparative genomic hybridization to map 461 chromosome breakpoints leading to large-scale chromosome imbalances in 56 primary neuroblastoma tumors and cell lines. Here, we analyze the distribution of DNA sequence elements and genomic landmarks found within these breakpoint intervals and in 15,800 randomly generated intervals of similar size. The most consistent finding was that neuroblastoma chromosome breakpoints occur preferentially in GC-rich regions of the genome. It is not unsurprising that these regions have fewer (AT)(n) microsatellite repeat sequences. In addition, chromosome breakpoints occurring in neuroblastoma also appeared to be preferentially associated with ancestral chromosome breakpoint regions on several chromosomes, suggesting that such sites also act as hotspots for chromosome rearrangement in somatic cells. Very little evidence for the enrichment of Alu and other types of repeats in breakpoint intervals was obtained. Overall, our results are consistent with a mechanistic model involving nonhomologous end joining of DNA double-strand breaks that have been generated in a nonrandom manner.

Entities:  

Mesh:

Year:  2007        PMID: 17574961     DOI: 10.1016/j.cancergencyto.2007.02.014

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Copy-number gains of HUWE1 due to replication- and recombination-based rearrangements.

Authors:  Guy Froyen; Stefanie Belet; Francisco Martinez; Cíntia Barros Santos-Rebouças; Matthias Declercq; Jelle Verbeeck; Lene Donckers; Siren Berland; Sonia Mayo; Monica Rosello; Márcia Mattos Gonçalves Pimentel; Natalia Fintelman-Rodrigues; Randi Hovland; Suely Rodrigues dos Santos; F Lucy Raymond; Tulika Bose; Mark A Corbett; Leslie Sheffield; Conny M A van Ravenswaaij-Arts; Trijnie Dijkhuizen; Charles Coutton; Veronique Satre; Victoria Siu; Peter Marynen
Journal:  Am J Hum Genet       Date:  2012-07-26       Impact factor: 11.025

2.  Ku70 acetylation in neuroblastoma pathogenesis and therapy.

Authors:  Valerie Castle; Roland Kwok; Anthony Opipari; Chitra Subramanian
Journal:  Trans Am Clin Climatol Assoc       Date:  2010

3.  Neuroblastoma in adolescents: genetic and clinical characterisation.

Authors:  Victoria Castel; Eva Villamón; Adela Cañete; Samuel Navarro; Amparo Ruiz; Carmen Melero; Antonio Herrero; Yania Yáñez; Rosa Noguera
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

4.  Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair.

Authors:  Marijke Bauters; Hilde Van Esch; Michael J Friez; Odile Boespflug-Tanguy; Martin Zenker; Angela M Vianna-Morgante; Carla Rosenberg; Jaakko Ignatius; Martine Raynaud; Karen Hollanders; Karen Govaerts; Kris Vandenreijt; Florence Niel; Pierre Blanc; Roger E Stevenson; Jean-Pierre Fryns; Peter Marynen; Charles E Schwartz; Guy Froyen
Journal:  Genome Res       Date:  2008-04-02       Impact factor: 9.043

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.